Cell cycle checkpoint kinase (CHK)1 inhibition induces immune modulation in recurrent BRCA wild-type high-grade serous ovarian cancer (HGSOC) patients

被引：0
|
作者：
Lampert, Erika J. [1 ]
Lee, Min-Jung [1 ]
Trepel, Jane B. [1 ]
Yuno, Akira [1 ]
Cimino-Mathews, Ashley [2 ]
Lee, Joo-Sang [1 ]
Ruppin, Eytan [1 ]
Nair, Jayakumar [1 ]
Ekwede, Irene [1 ]
Lee, Jung-Min [1 ]
机构：
[1] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-5000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5000
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
    Wong-Brown, Michelle W.
    van der Westhuizen, Andre
    Bowden, Nikola A.
    BMC CANCER, 2022, 22 (01)
  • [32] Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
    Michelle W. Wong-Brown
    Andre van der Westhuizen
    Nikola A. Bowden
    BMC Cancer, 22
  • [33] Assessing difference in the tumor and immune microenvironment of BRCA1/2 mutated versus BRCA wild type high grade serous ovarian cancers
    Qian, Jing
    Roman, Lynda D.
    Rajpara, Seeta
    Neuman, Monica
    Khetan, Varun
    Craig, David W.
    Carlson, Joseph
    Carpten, John D.
    CANCER RESEARCH, 2023, 83 (07)
  • [34] LKB1-MARK3 axis is a novel stress-activated cell cycle checkpoint and dysregulated in high-grade serous ovarian cancer
    Machino, Hidenori
    Kaneko, Syuzo
    Komatsu, Masaaki
    Asada, Ken
    Dozen, Ai
    Shozu, Kanto
    Hamamoto, Ryuji
    CANCER SCIENCE, 2021, 112 : 268 - 268
  • [35] A SYNERGISTIC ANTICANCER EFFECT OF COMBINATION TREATMENT WITH A CELL CYCLE CHECKPOINT KINASE 1 INHIBITOR AND PARP INHIBITOR IN BRCA WILD TYPE EPITHELIAL OVARIAN CANCER
    Kim, Y. B.
    Cho, H-Y
    Park, W. H.
    Suh, D. H.
    No, J. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A480 - A480
  • [36] Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells
    Khin, Manead
    Davis, Lydia J.
    Lantvit, Daniel D.
    Orjala, Jimmy
    Burdette, Joanna E.
    MOLECULAR PHARMACOLOGY, 2024, 106 (03) : 145 - 154
  • [37] Low PPP2R2A expression promotes sensitivity to CHK1 inhibition in high-grade serous ovarian cancer
    Qiu, Zhaojun
    Sigh, Deepika
    Liu, Yujie
    Prasad, Chandra B.
    Bean, Nichalos
    Yan, Chunhong
    Li, Zaibo
    Zhang, Xiaoli
    Narla, Goutham
    Difeo, Analisa
    Wang, Qi-En
    Zhang, Junran
    THERANOSTICS, 2024, 14 (19): : 7450 - 7469
  • [38] Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
    Wan, Changxin
    Keany, Matthew P.
    Dong, Han
    Al-Alem, Linah F.
    Pandya, Unnati M.
    Lazo, Suzan
    Boehnke, Karsten
    Lynch, Katherine N.
    Xu, Rui
    Zarrella, Dominique T.
    Gu, Shengqing
    Cejas, Paloma
    Lim, Klothilda
    Long, Henry W.
    Elias, Kevin M.
    Horowitz, Neil S.
    Feltmate, Colleen M.
    Muto, Michael G.
    Worley, Michael J.
    Berkowitz, Ross S.
    Matulonis, Ursula A.
    Nucci, Marisa R.
    Crum, Christopher P.
    Rueda, Bo R.
    Brown, Myles
    Liu, Xiaole Shirley
    Hill, Sarah J.
    CANCER RESEARCH, 2021, 81 (01) : 158 - 173
  • [39] Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids
    Singha, Bipradeb
    Laski, Jeremi
    Valdes, Yudith Ramos
    Liu, Elaine
    DiMattia, Gabriel E.
    Shepherd, Trevor G.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (05): : 1384 - 1399
  • [40] Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer
    Kim, Hyun-Soo
    Kim, Ji-Ye
    Lee, Yong Jae
    Kim, So Hee
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 414 - 421
12345